Yongli Ji - 12Emerson Hospital | 人才画像

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 7 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplemental Text from Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia

openalex（2024）

Cited0Views0Bibtex

Figure S3 from Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia

openalex（2024）

Cited0Views0Bibtex

Data from Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia

CANCER DISCOVERYno. 2 (2024): 240-257

Cited15Views0WOSBibtex

Abstract GS03-10: Allosteric PI3K-alpha Inhibition Overcomes On-Target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations

Cancer Researchno. 9_Supplement (2024): GS03-10

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn